DI SEBASTIANO, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 3.539
EU - Europa 2.538
AS - Asia 1.338
SA - Sud America 209
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 7.654
Nazione #
US - Stati Uniti d'America 3.523
SG - Singapore 637
IE - Irlanda 486
IT - Italia 394
CN - Cina 360
UA - Ucraina 333
SE - Svezia 326
DE - Germania 303
GB - Regno Unito 224
BR - Brasile 185
TR - Turchia 173
FR - Francia 123
FI - Finlandia 116
RU - Federazione Russa 90
IN - India 82
AT - Austria 28
BE - Belgio 22
NL - Olanda 18
VN - Vietnam 18
CZ - Repubblica Ceca 15
HK - Hong Kong 13
AR - Argentina 11
CA - Canada 10
JP - Giappone 9
BD - Bangladesh 8
ES - Italia 7
EU - Europa 7
GR - Grecia 6
IL - Israele 6
LT - Lituania 6
PL - Polonia 6
RO - Romania 6
ZA - Sudafrica 6
EE - Estonia 5
AU - Australia 4
BG - Bulgaria 4
CO - Colombia 4
MA - Marocco 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
EG - Egitto 3
KG - Kirghizistan 3
PK - Pakistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CH - Svizzera 2
DK - Danimarca 2
GL - Groenlandia 2
IQ - Iraq 2
JO - Giordania 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BT - Bhutan 1
CL - Cile 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 7.654
Città #
Chandler 842
Dublin 481
Jacksonville 459
Singapore 422
Ashburn 240
Princeton 224
Southend 157
Wilmington 121
Munich 116
Izmir 93
Beijing 88
Santa Clara 87
Nanjing 83
Chieti 82
Dearborn 75
Altamura 72
The Dalles 69
Los Angeles 57
Helsinki 56
Cambridge 51
Washington 49
Ann Arbor 46
Boardman 40
Woodbridge 34
Pescara 30
New York 28
Moscow 27
Brussels 22
Nanchang 22
Vienna 22
Nuremberg 18
Houston 17
Dong Ket 16
Falls Church 16
Shenyang 16
Tianjin 14
Brno 13
Hong Kong 13
Rome 13
Edinburgh 12
Frankfurt am Main 12
Kunming 12
Grevenbroich 11
London 11
Vittuone 11
Dallas 10
Jiaxing 10
Pune 10
Amsterdam 9
Hebei 9
Norwalk 9
Boston 8
Chicago 8
Hefei 8
São Paulo 8
Tokyo 8
Fairfield 7
San Francisco 7
Seattle 7
Turku 7
Ancona 6
Brooklyn 6
Changsha 6
Guangzhou 6
Istanbul 6
Milan 6
Redmond 6
Saint Louis 6
Warsaw 6
West Jordan 6
Arcore 5
Belo Horizonte 5
Bologna 5
Campinas 5
Francavilla al Mare 5
Hangzhou 5
Johannesburg 5
Lauterbourg 5
Redwood City 5
Rio de Janeiro 5
Romola 5
Stockholm 5
São José dos Campos 5
Toronto 5
Zhengzhou 5
Düsseldorf 4
Jinan 4
Kocaeli 4
L’Aquila 4
Macao 4
Montreal 4
Ningbo 4
Phoenix 4
Qingdao 4
Sofia 4
Athens 3
Augusta 3
Bari 3
Bishkek 3
Camerino 3
Totale 4.715
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 231
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 156
Totally laparoscopic complete mesocolon excision for splenic flexure cancer. A single institution experience 120
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 118
MICROSATELLITE ALTERATIONS IN PANCREATIC CARCINOMA 110
Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis 103
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells 103
Batimastat, A Matrix Metalloproyeinase inhibitor accellerates Healing in Rat Experimental Colitis 101
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 100
[Carcinoma of the male breast. Our experience]. 99
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 98
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 98
[Laparoscopic adrenalectomy: analysis of 65 cases] 97
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 95
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 95
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 92
Extracorporeal versus intracorporeal anastomosis after laparoscopic right hemicolectomy: cost-effectiveness analysis 92
Beneficial Effects of Batimastat (bb-94), a Matrix Metalloproteinase Inhibitor, in Rat Experimental Colitis 90
Totally laparoscopic complete mesocolon excision for splenic flexure cancer 90
Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients 87
Espressione del Connective Tissue Growth Factor (CTGF) nel cancro pancreatico 84
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 84
A modified fast-track program for pancreatic surgery: A prospective single-center experience 83
Influenza dei neurotrasmettitori algogeni sulla crescita cellulare nel cancro del pancreas 82
A surgical department for intensified care 81
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 80
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 79
Haemorrhoids and transient receptor potential vanilloid 1 77
Appendicitis: the role of nerves in pain generation 76
Endoscopic therapy for type B surgical biliary injury in a patient with short cystic duct. 76
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: A meta-analysis of prospective studies 76
A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable 76
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis 76
TRANSFORMING GROWTH FACTOR-BETA PATHWAY IS ACTIVATED IN CHOLECYSTOLITHIASIS 75
Time-qualified patterns of variation of PPAR γ, DNMT1, and DNMT3B expression in pancreatic cancer cell lines 75
Alterations of dna-repeats in pancreatic cancer 74
Alterations of dna-repeats in pancreatic cancer 73
Combined therapy in pancreatic cancer 71
The Pituitary Adenylate Cyclase-Activating Polypeptide Pathway is Activated in Human Chronic Pancreatitis. 71
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. 71
Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks 71
Determinant-based classification of acute pancreatitis severity: International multidisciplinary classification of acute pancreatitis severity: The 2013 German Edition [Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013] 71
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management 71
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 70
Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation 70
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis 69
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients 68
The techniques of duodenum preserving head resection of the pancreas in the treatment of chronic pancreatitis 68
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 68
Mirna expression profiles identify drivers in colorectal and pancreatic cancers 68
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 67
Changes in cytokine but not tachynin gene expression in patients with chronic pancreatitis 67
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients 67
Differential expression of connective tissue growth factor in inflammatory bowel disease. 66
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial 66
International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition 66
Support vector machine based on microRNA expression profiles to predict histological origin of ampullary carcinoma case report of a patient affected from adenocarcinoma of the papilla of vater with lynch syndrome 65
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly 65
The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification? 65
Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers 65
Mechanism of pain in chronic pancreatitis 64
Expression of interleukin-8 and substance P in human chronic pancreatitis 64
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: Single centre experience 64
Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease 64
Pathogenesis of pain in chronic pancreatitis 63
Desmoplastic reaction influences pancreatic cancer growth behavior 62
Neuroimmune appendicitis: a new pathological entity? 62
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 62
Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer 62
How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer 61
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis 60
Key Role of Phosphoinositide 3-kinase Class IB in Pancreatic Cancer. 59
Cathepsins and pancreatic cancer: The 2012 update. 59
Phosphatidylserine receptor in chronic pancreatitis: Evidence for a macrophage independent role 59
Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction 59
Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease 59
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy 59
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation 59
Substance P and neprilysin in chronic pancreatitis 58
Italian consensus guidelines for chronic pancreatitis 58
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix 58
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases 58
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 58
Chemokine receptor CXCR4: Role in gastrointestinal cancer 57
Combined modality treatments in pancreatic cancer 56
Phosphoinositide 3-Kinase Class IB plays a key role in human pancreatic cancer 55
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. 55
Mapping of Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer 54
Immune cells infiltration and the expression of growth associated protein-43 expression correlate with pain in chronic pancreatisis 54
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis 54
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 54
Key role of Phosphoinositide 3-Kinase Class IB in pancreatic cancer 53
Immune cell infiltration and Growth associated protein-43 correlate with pain in chronic pancreatitis. 53
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma 53
Pain and pain generation in pancreatic cancer 53
The neuroimmune connection in chronic pancreatisis 52
Cronic pancreatitis: evidence for neurogenic inflammation 52
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer 52
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels 52
null 52
Totale 7.370
Categoria #
all - tutte 38.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 0 21
2020/2021720 105 14 119 28 65 165 20 18 38 91 16 41
2021/2022595 25 28 16 99 32 10 4 38 36 5 73 229
2022/20232.049 200 312 123 269 143 366 99 183 220 24 76 34
2023/2024904 58 35 81 26 80 300 157 58 1 33 6 69
2024/20251.931 114 349 239 81 68 118 129 140 270 81 253 89
Totale 8.154